Ban Seung Pil, Kwon O-Ki, Kim Young Deok
Department of Neurosurgery, Seoul National University Bundang Hospital, Seongnam, Korea.
Department of Neurosurgery, Seoul National University College of Medicine, Seoul, Korea.
J Korean Neurosurg Soc. 2022 Jan;65(1):40-48. doi: 10.3340/jkns.2021.0191. Epub 2021 Dec 10.
Placement of a single transverse stent via the nondominant A1 across the anterior communicating artery (AComA) into the contralateral A2 can provide sufficient neck coverage for wide-necked bifurcation AComA aneurysms. The authors described the feasibility, safety and long-term outcomes of this technique.
Between January 2015 and February 2018, placement of a single transverse stent via the nondominant A1 was attempted in 17 wide-necked bifurcation AComA aneurysms. The authors reviewed the medical records and radiological studies.
The technical success rate was 94.1% (16/17). Periprocedural thromboembolic complications occurred in one patient (6.3%) without permanent neurological deficits. The mean clinical follow-up duration was 39.9±9.8 months. No deaths or delayed thromboembolic complications occurred. The mean angiographic follow-up duration was 38.9±9.8 months. The immediate and final follow-up complete occlusion rates were 87.4 and 93.7%, respectively. There was no recanalization during the follow-up period.
Placement of a single transverse stent via the nondominant A1 across the AComA into the contralateral A2 is a feasible and relatively safe endovascular technique for the treatment of wide-necked bifurcation AComA aneurysms, with good long-term occlusion rates and a reasonable complication rate, if only the nondominant A1 is applicable.
经非优势侧A1将单个横向支架穿过前交通动脉(AComA)置入对侧A2,可为宽颈分叉型AComA动脉瘤提供足够的瘤颈覆盖。作者描述了该技术的可行性、安全性及长期疗效。
2015年1月至2018年2月,对17例宽颈分叉型AComA动脉瘤尝试经非优势侧A1置入单个横向支架。作者回顾了病历及影像学研究。
技术成功率为94.1%(16/17)。1例患者(6.3%)发生围手术期血栓栓塞并发症,但无永久性神经功能缺损。平均临床随访时间为39.9±9.8个月。无死亡或延迟性血栓栓塞并发症发生。平均血管造影随访时间为38.9±9.8个月。即刻及最终随访时的完全闭塞率分别为87.4%和93.7%。随访期间无再通情况。
经非优势侧A1将单个横向支架穿过AComA置入对侧A2,对于治疗宽颈分叉型AComA动脉瘤是一种可行且相对安全的血管内技术,只要非优势侧A1适用,其长期闭塞率良好且并发症发生率合理。